Generic versions of the weight loss drug are about to hit the market
Colby Cosh is a Columnist at the National Post. He covers a diverse range of topics including business and economics, law and legal affairs, and world affairs, with a focus on current affairs, federal legislation, and economic policy. Colby's work has been featured in various publications including the Regina Leader-Post, SaltWire Network, and Winnipeg Sun.














